These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1469696)

  • 1. A novel orally active inhibitor of IL-1 generation: synthesis and structure-activity relationships of 3-(4-hydroxy-1-naphthalenyl)-2-propenoic acid derivatives.
    Tanaka M; Chiba K; Okita M; Kaneko T; Tagami K; Hibi S; Okamoto Y; Shirota H; Goto M; Obaishi H
    J Med Chem; 1992 Dec; 35(25):4665-75. PubMed ID: 1469696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(5-Alkyl-4-hydroxy-3-methoxy-1-naphthalenyl)-2-methyl-2-propenoic acids as orally active inhibitors of IL-1 generation.
    Tanaka M; Chiba K; Okita M; Kaneko T; Tagami K; Hibi S; Okamoto Y; Shirota H; Goto M; Sakurai H
    J Med Chem; 1991 Aug; 34(8):2647-9. PubMed ID: 1875355
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel inhibitor of IL-1 generation, E5090: in vivo inhibitory effect on the generation of IL-1-like factor and on granuloma formation in an air-pouch model.
    Chiba K; Goto M; Shirota H
    Agents Actions Suppl; 1991; 32():231-5. PubMed ID: 2069092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel inhibitor of IL-1 generation, E5090: in vitro inhibitory effects on the generation of IL-1 by human monocytes.
    Goto M; Chiba K; Hashida R; Shirota H
    Agents Actions Suppl; 1991; 32():225-9. PubMed ID: 2069091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiinflammatory properties of E5090, a novel orally active inhibitor of IL-1 generation.
    Shirota H; Chiba K; Goto M; Hashida R; Ono H
    Agents Actions Suppl; 1991; 32():219-23. PubMed ID: 2069090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).
    van Veldhoven JP; Blad CC; Artsen CM; Klopman C; Wolfram DR; Abdelkadir MJ; Lane JR; Brussee J; Ijzerman AP
    Bioorg Med Chem Lett; 2011 May; 21(9):2736-9. PubMed ID: 21167710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity.
    Batt DG; Maynard GD; Petraitis JJ; Shaw JE; Galbraith W; Harris RR
    J Med Chem; 1990 Jan; 33(1):360-70. PubMed ID: 2104936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
    Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
    J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II.
    Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N
    Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.
    Wrobel J; Millen J; Sredy J; Dietrich A; Gorham BJ; Malamas M; Kelly JM; Bauman JG; Harrison MC; Jones LR
    J Med Chem; 1991 Aug; 34(8):2504-20. PubMed ID: 1908522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
    Yatabe T; Kawai Y; Oku T; Tanaka H
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):966-72. PubMed ID: 9658575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
    Mewshaw RE; Hild EK; Commons TJ; Strike DP
    Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 2-(2'-cyclopentyl)- and 2-(2'-cyclohexyl) substituted 1-naphthol derivatives with anticyclooxygenase activity.
    Kongkathip N; Hasitapan K; Pradidphol N; Kirtikara K; Jongkona N; Kongkathip B
    Curr Med Chem; 2006; 13(30):3663-74. PubMed ID: 17168729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
    Musser JH; Kubrak DM; Chang J; Lewis AJ
    J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17,20-lyase inhibitors. Part 4: design, synthesis and structure-activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors.
    Kaku T; Matsunaga N; Ojida A; Tanaka T; Hara T; Yamaoka M; Kusaka M; Tasaka A
    Bioorg Med Chem; 2011 Mar; 19(5):1751-70. PubMed ID: 21316976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bioactivities of novel 5,6-bis(4-methoxyphenyl)-2H-pyridazin-3-one derivatives: inhibitors of interleukin-1 beta (IL-1beta) production.
    Matsuda T; Aoki T; Koshi T; Ohkuchi M; Shigyo H
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2373-5. PubMed ID: 11527734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.
    Hamel P; Riendeau D; Brideau C; Chan CC; Desmarais S; Delorme D; Dubé D; Ducharme Y; Ethier D; Grimm E; Falgueyret JP; Guay J; Jones TR; Kwong E; McAuliffe M; McFarlane CS; Piechuta H; Roumi M; Tagari P; Young RN; Girard Y
    J Med Chem; 1997 Aug; 40(18):2866-75. PubMed ID: 9288168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.
    Song S; Lee H; Jin Y; Ha YM; Bae S; Chung HY; Suh H
    Bioorg Med Chem Lett; 2007 Jan; 17(2):461-4. PubMed ID: 17064896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
    Bird ; Bruneau P; Crawley GC; Edwards MP; Foster SJ; Girodeau JM; Kingston JF; McMillan RM
    J Med Chem; 1991 Jul; 34(7):2176-86. PubMed ID: 1648621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.